Fig. 3From: Optimal strategies to screen health care workers for COVID-19 in the US: a cost-effectiveness analysisProbability distribution of difference in net costs with Ag vs. PCR-only testing in early clinical disease, days 1–7. PCR screening has fewer net costs than Ag testing in 26% of simulationsBack to article page